Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$51.32 - $68.5 $1.21 Million - $1.62 Million
-23,621 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$47.03 - $57.12 $67,064 - $81,453
1,426 Added 6.42%
23,621 $1.3 Million
Q3 2021

Nov 12, 2021

BUY
$52.17 - $70.2 $224,852 - $302,562
4,310 Added 24.1%
22,195 $1.17 Million
Q2 2021

Aug 12, 2021

SELL
$68.86 - $83.34 $198,661 - $240,435
-2,885 Reduced 13.89%
17,885 $1.23 Million
Q1 2021

May 14, 2021

BUY
$76.15 - $111.94 $101,584 - $149,327
1,334 Added 6.86%
20,770 $1.6 Million
Q4 2020

Feb 11, 2021

SELL
$96.85 - $148.25 $154,766 - $236,903
-1,598 Reduced 7.6%
19,436 $1.92 Million
Q3 2020

Nov 10, 2020

SELL
$122.47 - $213.56 $472,121 - $823,273
-3,855 Reduced 15.49%
21,034 $2.99 Million
Q2 2020

Aug 10, 2020

SELL
$185.52 - $231.25 $806,640 - $1.01 Million
-4,348 Reduced 14.87%
24,889 $4.91 Million
Q1 2020

May 12, 2020

BUY
$143.0 - $274.03 $803,374 - $1.54 Million
5,618 Added 23.79%
29,237 $7.22 Million
Q4 2019

Jan 24, 2020

SELL
$146.12 - $215.82 $78,904 - $116,542
-540 Reduced 2.24%
23,619 $4.89 Million
Q3 2019

Nov 05, 2019

SELL
$130.44 - $187.64 $53,741 - $77,307
-412 Reduced 1.68%
24,159 $3.69 Million
Q2 2019

Jul 18, 2019

SELL
$111.45 - $128.93 $116,242 - $134,473
-1,043 Reduced 4.07%
24,571 $3.17 Million
Q1 2019

Apr 18, 2019

BUY
$89.61 - $117.78 $430,217 - $565,461
4,801 Added 23.07%
25,614 $3.02 Million
Q4 2018

Jan 25, 2019

SELL
$87.81 - $110.65 $34,597 - $43,596
-394 Reduced 1.86%
20,813 $1.91 Million
Q3 2018

Oct 17, 2018

BUY
$90.63 - $120.22 $569,972 - $756,063
6,289 Added 42.16%
21,207 $2.09 Million
Q2 2018

Jul 27, 2018

BUY
$88.4 - $105.34 $227,541 - $271,145
2,574 Added 20.85%
14,918 $1.38 Million
Q1 2018

Apr 06, 2018

BUY
$94.51 - $120.23 $94,604 - $120,350
1,001 Added 8.82%
12,344 $1.23 Million
Q4 2017

Jan 25, 2018

SELL
$84.48 - $104.02 $71,723 - $88,312
-849 Reduced 6.96%
11,343 $1.06 Million
Q3 2017

Oct 03, 2017

BUY
$73.17 - $103.47 $892,088 - $1.26 Million
12,192
12,192 $1.24 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.81B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.